KalVista Pharmaceuticals, Inc. Annual Net Cash Provided by (Used in) Investing Activities in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
KalVista Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from 2015 to 2023.
  • KalVista Pharmaceuticals, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending July 31, 2024 was $37.2M, a 89.5% increase year-over-year.
  • KalVista Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$84.7M, a 305% decline from 2022.
  • KalVista Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was $41.4M, a 28.4% decline from 2021.
  • KalVista Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was $57.9M.
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$84.7M -$126M -305% May 1, 2023 Apr 30, 2024 10-K 2024-07-11
2022 $41.4M -$16.4M -28.4% May 1, 2022 Apr 30, 2023 10-K 2024-07-11
2021 $57.9M +$206M May 1, 2021 Apr 30, 2022 10-K 2024-07-11
2020 -$148M -$164M -981% May 1, 2020 Apr 30, 2021 10-K 2023-07-10
2019 $16.8M +$86.2M May 1, 2019 Apr 30, 2020 10-K 2022-07-07
2018 -$69.4M -$68M -4765% May 1, 2018 Apr 30, 2019 10-K 2021-07-13
2017 -$1.43M -$35.5M -104% May 1, 2017 Apr 30, 2018 10-K 2020-07-01
2016 $34.1M +$34.1M May 1, 2016 Apr 30, 2017 10-K 2019-07-16
2015 -$11K* May 1, 2015 Apr 30, 2016 10-K 2018-07-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.